Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 102, Issue 10 , Pages 955-965 , October 2008

The clinical consequences of strain diversity in Mycobacterium tuberculosis

  • Mark P. Nicol

      Affiliations

    • Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa
    • Department of Clinical Laboratory Sciences, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa
    • Corresponding Author InformationCorresponding author. Tel.: +27 21 406 6079; fax: +27 21 406 6796.
    • ,
  • Robert J. Wilkinson

      Affiliations

    • Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa
    • Division of Medicine, Imperial College, South Kensington Campus, London SW7 2AZ, UK
    • National Institute for Medical Research, Mill Hill, London NW7 1AA, UK
    • Department of Medicine, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa

Received 11 January 2008 ,Revised 28 March 2008 ,Accepted 31 March 2008.

References 

  1. Abebe F, Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?. Clin. Exp. Immunol. 2006;145:389–397
  2. Agerton TB, Valway SE, Blinkhorn RJ, Shilkret KL, Reves R, Schluter WW, et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin. Infect. Dis. 1999;29:85–92
  3. Alcais A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: two distinct genetic diseases. J. Exp. Med. 2005;202:1617–1621
  4. Alland D, Whittam TS, Murray MB, Cave MD, Hazbon MH, Dix K, et al. Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis. J. Bacteriol. 2003;185:3392–3399
  5. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 1998;280:1432–1435
  6. Anderson ST, Williams AJ, Brown JR, Newton SM, Simsova M, Nicol MP, et al. Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing. Am. J. Respir. Crit. Care Med. 2006;173:1038–1042
  7. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg. Infect. Dis. 2000;6:302–305
  8. Becq J, Gutierrez MC, Rosas-Magallanes V, Rauzier J, Gicquel B, Neyrolles O, et al. Contribution of horizontally acquired genomic islands to the evolution of the tubercle bacilli. Mol. Biol. Evol. 2007;24:1861–1871
  9. Bhatia AL, Csillag A, Mitchison DA, Selkon JB, Somasundaram PR, Subbaiah TV. The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 2. Comparison with virulence of tubercle bacilli from British patients. Bull. World Health Organ. 1961;25:313–322
  10. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 2002;10:45–52
  11. Bishai WR, Dannenberg AM, Parrish N, Ruiz R, Chen P, Zook BC, et al. Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect. Immun. 1999;67:4931–4934
  12. Broad Institute, 2007. Mycobacterium tuberculosis database. http://www.broad.mit.edu/annotation/genome/mycobacterium_tuberculosis_spp/KZNDownloads.html [accessed 10 January 2008].
  13. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 2003;187:1424–1432
  14. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Garcia I, Cabrera P, et al. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am. J. Respir. Crit. Care Med. 2001;164:1165–1170
  15. Caws M, Thwaites G, Stepniewska K, Nguyen TN, Nguyen TH, Nguyen TP, et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J. Clin. Microbiol. 2006;44:3934–3939
  16. Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, et al. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin. Infect. Dis. 2007;44:1421–1427
  17. Dale JW, Bothamley GH, Drobniewski F, Gillespie SH, McHugh TD, Pitman R. Origins and properties of Mycobacterium tuberculosis isolates in London. J. Med. Microbiol. 2005;54:575–582
  18. Dormans J, Burger M, Aguilar D, Hernandez-Pando R, Kremer K, Roholl P, et al. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin. Exp. Immunol. 2004;137:460–468
  19. Drobniewski F, Balabanova Y, Ruddy M, Weldon L, Jeltkova K, Brown T, et al. Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the Beijing strain family. Emerg. Infect. Dis. 2002;8:1320–1326
  20. Dunn PL, North RJ. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 1995;63:3428–3437
  21. Eilers PH, van Soolingen D, Thi Ngoc Lan N, Warren RM, Borgdorff MW. Transposition rates of Mycobacterium tuberculosis IS6110 restriction fragment length polymorphism patterns. J. Clin. Microbiol. 2004;42:2461–2464
  22. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis . Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg. Infect. Dis. 2006;12:736–743
  23. Filliol I, Driscoll JR, van Soolingen D, Kreiswirth BN, Kremer K, Valetudie G, et al. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg. Infect. Dis. 2002;8:1347–1349
  24. Filliol I, Motiwala AS, Cavatore M, Qi W, Hazbon MH, Bobadilla del Valle M, et al. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J. Bacteriol. 2006;188:759–772
  25. Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J. Bacteriol. 2002;184:5479–5490
  26. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 2007;7:328–337
  27. Gagneux, S., Small, P.M., 2007b. Evolution of Mycobacterium tuberculosis. Keystone Symposia: Tuberculosis: From Lab Research to Field Trials. Keystone Symposia, Silverthorne, CO.
  28. Gagneux S, Burgos MV, Deriemer K, Encisco A, Munoz S, Hopewell PC, et al. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog. 2006;2:e61
  29. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science. 2006;312:1944–1946
  30. Gagneux S, Deriemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, et al. Variable host–pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 2006;103:2869–2873
  31. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575–1580
  32. Garcia de Viedma D, Lorenzo G, Cardona PJ, Rodriguez NA, Gordillo S, Serrano MJ, et al. Association between the infectivity of Mycobacterium tuberculosis strains and their efficiency for extrarespiratory infection. J. Infect. Dis. 2005;192:2059–2065
  33. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 2002;8:843–849
  34. Glynn JR, Crampin AC, Yates MD, Traore H, Mwaungulu FD, Ngwira BM, et al. The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi. J. Infect. Dis. 2005;192:480–487
  35. Gori A, Esposti AD, Bandera A, Mezzetti M, Sola C, Marchetti G, et al. Comparison between spoligotyping and IS6110 restriction fragment length polymorphisms in molecular genotyping analysis of Mycobacterium tuberculosis strains. Mol. Cell. Probes. 2005;19:236–244
  36. Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A, et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J. Clin. Invest. 2005;115:2472–2479
  37. Hawkey CR, Yap T, Pereira J, Moore DA, Davidson RN, Pasvol G, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin. Infect. Dis. 2005;40:1368–1371
  38. Hirsh AE, Tsolaki AG, Deriemer K, Feldman MW, Small PM. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc. Natl. Acad. Sci. USA. 2004;101:4871–4876
  39. Johnson R, Warren R, Strauss OJ, Jordaan AM, Falmer AA, Beyers N, et al. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int. J. Tuberc. Lung Dis. 2006;10:1412–1414
  40. Kam KM, Yip CW, Tse LW, Wong KL, Lam TK, Kremer K, et al. Utility of mycobacterial interspersed repetitive unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis isolates of the Beijing family. J. Clin. Microbiol. 2005;43:306–313
  41. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 1997;35:907–914
  42. Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J. Clin. Invest. 2005;115:2480–2488
  43. Kapogiannis BG, Satola S, Keyserling HL, Farley MM. Invasive infections with Haemophilus influenzae serotype a containing an IS1016–bexA partial deletion: possible association with virulence. Clin. Infect. Dis. 2005;41:e97–e103
  44. Karaolis DK, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc. Natl. Acad. Sci. USA. 1998;95:3134–3139
  45. Kato-Maeda M, Rhee JT, Gingeras TR, Salamon H, Drenkow J, Smittipat N, et al. Comparing genomes within the species Mycobacterium tuberculosis. Genome Res. 2001;11:547–554
  46. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 2001;345:1098–1104
  47. Kong Y, Cave MD, Zhang L, Foxman B, Marrs CF, Bates JH, et al. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J. Clin. Microbiol. 2007;45:409–414
  48. Kumar A, Toledo JC, Patel RP, Lancaster JR, Steyn AJ. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc. Natl. Acad. Sci. USA. 2007;104:11568–11573
  49. Lan NT, Lien HT, Tung le B, Borgdorff MW, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg. Infect. Dis. 2003;9:1633–1635
  50. Lari N, Rindi L, Bonanni D, Tortoli E, Garzelli C. Mutations in mutT genes of Mycobacterium tuberculosis isolates of Beijing genotype. J. Med. Microbiol. 2006;55:599–603
  51. Liu X, Gutacker MM, Musser JM, Fu YX. Evidence for recombination in Mycobacterium tuberculosis. J. Bacteriol. 2006;188:8169–8177
  52. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 2003;133:30–37
  53. Manca C, Tsenova L, Barry CE, Bergtold A, Freeman S, Haslett PA, et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 1999;162:6740–6746
  54. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. USA. 2001;98:5752–5757
  55. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med. 2007;176:208–213
  56. McEvoy CR, Falmer AA, van Pittius NC, Victor TC, van Helden PD, Warren RM. The role of IS6110 in the evolution of Mycobacterium tuberculosis. Tuberculosis (Edinb.). 2007;87:393–404
  57. McMurray DN, Bartow RA, Mintzer CL, Hernandez-Frontera E. Micronutrient status and immune function in tuberculosis. Ann. N. Y. Acad. Sci. 1990;587:59–69
  58. Mitchison DA, Wallace JG, Bhatia AL, Selkon JB, Subbaiah TV, Lancaster MC. A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli. Tubercle. 1960;41:1–22
  59. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int. J. Tuberc. Lung Dis. 2008;12:99–104
  60. Mollick JA, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 1993;92:710–719
  61. Narvskaya O, Otten T, Limeschenko E, Sapozhnikova N, Graschenkova O, Steklova L, et al. Nosocomial outbreak of multidrug-resistant tuberculosis caused by a strain of Mycobacterium tuberculosis W-Beijing family in St. Petersburg, Russia. Eur. J. Clin. Microbiol. Infect. Dis. 2002;21:596–602
  62. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 1996;335:1941–1949
  63. Newton SM, Smith RJ, Wilkinson KA, Nicol MP, Garton NJ, Staples KJ, et al. A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc. Natl. Acad. Sci. USA. 2006;103:15594–15598
  64. Nicol MP, Sola C, February B, Rastogi N, Steyn L, Wilkinson RJ. Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape Town, South Africa. J. Clin. Microbiol. 2005;43:5779–5781
  65. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, Shanley C, et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent Th1 response followed by rapid down-regulation. J. Immunol. 2007;179:522–531
  66. Otal I, Martin C, Vincent-Levy-Frebault V, Thierry D, Gicquel B. Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis. J. Clin. Microbiol. 1991;29:1252–1254
  67. Petrelli D, Kaushal Sharma M, Wolfe J, Al-Azem A, Hershfield E, Kabani A. Strain-related virulence of the dominant Mycobacterium tuberculosis strain in the Canadian province of Manitoba. Tuberculosis (Edinb.). 2004;84:317–326
  68. Pillay M, Sturm AW. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin. Infect. Dis. 2007;45:1409–1414
  69. Qian L, Van Embden JD, van der Zanden AG, Weltevreden EF, Duanmu H, Douglas JT. Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues. J. Clin. Microbiol. 1999;37:471–474
  70. Rad ME, Bifani P, Martin C, Kremer K, Samper S, Rauzier J, et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg. Infect. Dis. 2003;9:838–845
  71. Ramakrishnan CV, Bhatia AL, Fox W, Mitchison DA, Radhakrishna S, Selkon JB, et al. The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 3. Virulence related to pretreatment status of disease and to response to chemotherapy. Bull. World Health Organ. 1961;25:323–338
  72. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature. 2004;431:84–87
  73. Reed MB, Gagneux S, Deriemer K, Small PM, Barry CE. The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J. Bacteriol. 2007;189:2583–2589
  74. Rhee JT, Piatek AS, Small PM, Harris LM, Chaparro SV, Kramer FR, et al. Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis. J. Clin. Microbiol. 1999;37:1764–1770
  75. Scholl P, Diez A, Mourad W, Parsonnet J, Geha RS, Chatila T. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA. 1989;86:4210–4214
  76. Shelburne SA, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev. 2003;5:67–79
  77. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N. Engl. J. Med. 1994;330:1703–1709
  78. Sola C, Filliol I, Gutierrez MC, Mokrousov I, Vincent V, Rastogi N. Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives. Emerg. Infect. Dis. 2001;7:390–396
  79. Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA. 1997;94:9869–9874
  80. Supply P, Mazars E, Lesjean S, Vincent V, Gicquel B, Locht C. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol. Microbiol. 2000;36:762–771
  81. Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J. Clin. Microbiol. 2001;39:3563–3571
  82. Talarico S, Donald CM, Foxman B, Marrs CF, Zhang L, Bates JH, et al. Association of Mycobacterium tuberculosis PE_PGRS33 polymorphism with clinical and epidemiological characteristics. Tuberculosis (Edinb.). 2007;87:338–346
  83. Tanaka MM, Francis AR. Detecting emerging strains of tuberculosis by using spoligotypes. Proc. Natl. Acad. Sci. USA. 2006;103:15266–15271
  84. Theus SA, Cave MD, Eisenach KD. Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics. J. Infect. Dis. 2005;191:453–460
  85. Theus SA, Cave MD, Eisenach K, Walrath J, Lee H, Mackay W, et al. Differences in the growth of paired Ugandan isolates of Mycobacterium tuberculosis within human mononuclear phagocytes correlate with epidemiological evidence of strain virulence. Infect. Immun. 2006;74:6865–6876
  86. Thwaites G, Caws M, Chau TT, D'Sa A, Lan NT, Huyen MN, et al. The relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J. Clin. Microbiol. 2008;46:1363–1368
  87. Tracevska T, Jansone I, Baumanis V, Marga O, Lillebaek T. Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int. J. Tuberc. Lung Dis. 2003;7:1097–1103
  88. Tsenova L, Ellison E, Harbacheuski R, Moreira AL, Kurepina N, Reed MB, et al. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J. Infect. Dis. 2005;192:98–106
  89. Tsenova L, Harbacheuski R, Sung N, Ellison E, Fallows D, Kaplan G. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine. 2007;25:5126–5132
  90. Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere YO, Kreiswirth BN, van Soolingen D, et al. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J. Clin. Microbiol. 2005;43:3185–3191
  91. Valway SE, Sanchez MP, Shinnick TF, Orme I, Agerton T, Hoy D, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 1998;338:633–639
  92. van Crevel R, Nelwan RH, de Lenne W, Veeraragu Y, van der Zanden AG, Amin Z, et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg. Infect. Dis. 2001;7:880–883
  93. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 1999;341:1174–1179
  94. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J. Clin. Microbiol. 1995;33:3234–3238
  95. Victor TC, Streicher EM, Kewley C, Jordaan AM, van der Spuy GD, Bosman M, et al. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int. J. Tuberc. Lung Dis. 2007;11:195–201
  96. WHO, 2007. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2007. World Health Organization, Geneva, WHO/HTM/TB/2007.376.
  97. Yang Z, Yang D, Kong Y, Zhang L, Marrs CF, Foxman B, et al. Clinical relevance of Mycobacterium tuberculosis plcD gene mutations. Am. J. Respir. Crit. Care Med. 2005;171:1436–1442
  98. Zhang M, Gong J, Yang Z, Samten B, Cave MD, Barnes PF. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J. Infect. Dis. 1999;179:1213–1217

PII: S0035-9203(08)00146-6

doi: 10.1016/j.trstmh.2008.03.025

Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 102, Issue 10 , Pages 955-965 , October 2008

Article Tools

* Image Usage & Resolution